- Easy to fit, single use lens
- Corrects refractive error and slows the elongation of the eye through ActivControlTM Technology
- Suitable for children as young as 8**
The MiSight® 1 day lens is clinically proven to slow the progression of myopia when initially prescribed for children 8-12 years old*. It serves as the cornerstone of a comprehensive myopia management approach that we expect to launch in the U.S. in Spring 2020.
MiSight 1 day contact lenses were clinically validated in a multi-year comprehensive study that enrolled children between 8 and 12.
Over three years, MiSight reduced myopia progression by 59%, versus a single vision 1 day lens.1
The clinical study of MiSight 1 day lenses was the first to demonstrate sustained reduction in myopia progression with a soft contact lense over a three-year period.1†
With MiSight, we also saw 52% reduction in average axial lengthening1†
Change in axial length
How MiSight 1 day works
MiSight 1 day with ActivControl™ Technology helps slow the elongation of the eye and myopia progression, while fully correcting refractive error.1 Addressing axial elongation helps to reduce the risk of myopia-related vision complications later in life, including irreversible vision loss.2
- Two treatment zones create myopic defocus with image focus in front of the retina, rather than behind it to slow axial elongation
- Two correction zones correct myopia in all gaze positions
*Indications for Use: MiSight® (omafilcon A) daily wear single use Soft Contact Lenses are indicated for the correction of myopic ametropia and for slowing the progression of myopia in children with non-diseased eyes, who at the initiation of treatment are 8-12 years of age and have a refraction of -0.75 to -4.00 diopters (spherical equivalent) with ≤ 0.75 diopters of astigmatism. The lens is to be discarded after each removal.
**Based on a clinical study in which participants were between the ages of 8 and 12 at initial fit.
†Compared with a standard single vision, 1 day lens over a three-year period
1. Chamberlain P, et al. A 3-Year Randomized Clinical Trial of MiSight Lenses for Myopia Control. Optom Vis Sci. 2019;96(8):556-7. 2. Tideman JW, et al. Association of Axial Length With Risk of Uncorrectable Visual Impairment for Europeans With Myopia. JAMA Ophthalmol. 2016;134(12):1355-63.